Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy

Vaccine

Volumn 31, Issue 51, 2013, Pages 6043-6045

  Daly, Janet M ^a   Elton, Debra ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Efficacy; Equine; Influenza; Vaccine

Indexed keywords

EQUINE INFLUENZA VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; EQUINE INFLUENZA; HORSE; INFLUENZA VIRUS A H3N8; MEDICAL DECISION MAKING; NONHUMAN; PRIORITY JOURNAL; VIRULENCE; VIRUS STRAIN;

EFFICACY; EQUINE; INFLUENZA; VACCINE;

ANIMALS; ANTIGENS, VIRAL; CROSS PROTECTION; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84888434716     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.070     Document Type: Article

References (20)

1. Elton D., Bryant N. Facing the threat of equine influenza. Equine Vet J 2011, 43:250-258.
2. Kawaoka Y., Bean W.J., Webster R.G. Evolution of the hemagglutinin of equine H3 influenza viruses. Virology 1989, 169:283-292.
3. Daly J., Lai A., Binns M., Chambers T., Barrandeguy M., Mumford J. Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol 1996, 77:661-671.
4. Lai A.C., Rogers K.M., Glaser A., Tudor L., Chambers T. Alternate circulation of recent equine-2 influenza viruses (H3N8) from two distinct lineages in the United States. Virus Res 2004, 100:159-164.
5. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., et al. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 2009, 138:41-52.
6. Anon OIE expert surveillance panel on equine influenza vaccine composition 2012, 46-49. OIE Bulletin.
7. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771.
8. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., et al. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 2005, 336:113-119.
9. Park A.W., Daly J.M., Lewis N.S., Smith D.J., Wood J.L., Grenfell B.T. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 2009, 326:726-728.
10. Deem M.W., Lee H.Y. Sequence space localization in the immune system response to vaccination and disease. Phys Rev Lett 2003, 91:068101.
11. Gupta V., Earl D.J., Deem M.W. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 2006, 24:3881-3888.
12. Lee M.S., Chen J.S. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 2004, 10:1385-1390.
13. Pan K., Subieta K.C., Deem M.W. A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains. PEDS 2011, 24:291-299.
14. Daniels R.S., Skehel J.J., Wiley D.C. Amino acid sequences of haemagglutinins of influenza viruses of the H3 subtype isolated from horses. J Gen Virol 1985, 66:457-464.
15. Daly J.M., Yates P.J., Newton J.R., Park A., Henley W., Wood J.L., et al. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 2004, 22:4101-4109.
16. Daly J.M., Yates R.J., Browse G., Swann Z., Newton J.R., Jessett D., et al. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet J 2003, 35:458-462.
17. Yates P., Mumford J.A. Equine influenza vaccine efficacy: the significance of antigenic variation. Vet Microbiol 2000, 74:173-177.
18. OIE Equine influenza. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, 7th ed.
19. Mumford J.A., Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev Biol Stand 1992, 79:137-146.
20. Wattrang E., Jessett D.M., Yates P., Fuxler L., Hannant D. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunol 2003, 16:57-67.